This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).
Web Desc
Cancer Control by Tumor Suppressors and Immune Effectors
joint with Dendritic Cells and the Initiation of Adaptive Immunity
Organizer(s): Laurence Zitvogel, Anna Karolina Palucka and Mark J. Smyth
Date: February 12 - 17, 2011
Location: Santa Fe Community Convention Center, Santa Fe, NM, USA
Sponsored by Abbott Laboratories and Genzyme Corporation
Summary of Meeting:
The changes in the cell biology of tumor cells are conditioned by epigenetic and genetic reprogramming, genomic instability being an essential feature of both oncogenesis and tumor progression despite intrinsic tumor suppressing barriers. These modifications of cancer cells can be accompanied by the emission of “danger signals” that can be perceived by the innate and cognate immune systems. Likewise, promoting tumor cell death or autophagy may enhance or probe the activation of the immune system. Therefore, unravelling the links between the intrinsic barriers against tumor progression and the extrinsic anticancer checkpoints may contribute to unravelling the key molecular sensors of the host-tumor equilibrium and create novel therapeutic targets. The major objectives will be as follows: 1) examine the molecular links between tumor intrinsic checkpoints (p53, NF-Kappa B, autophagy, DNA damage response…) and immunity or immunosuppression, 2) explore the indirect effects of anticancer therapies (conventional or targeted) on the immune system, 3) describe the rationale for and the potential benefit of novel strategies of cancer vaccines or immunotherapies exploiting this knowledge.
Scholarship Deadline: October 13 2010
Discounted Abstract Deadline: October 13 2010
Abstract Deadline: November 17 2010
Discounted Registration Deadline: December 13 2010
We gratefully acknowledge additional support for this conference from:
Abbott Laboratories
Genentech, Inc.
Genzyme CorporationSAIC
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Celldex Therapeutics, Inc.

GlaxoSmithKline Biologicals
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found